|
Bio-Medisinsk Innovasjon AS (BMI) offers you the pick of the exciting new biomedical investment opportunities coming out of Norway. We act as an investor and incubator for start-ups, cooperating closely with Medinnova, the TTO for several of the country’s leading hospitals such as Rikshospitalet-Radiumhospitalet and Ullevål University hospitals. We also collaborate with Birkeland Innovasjon AS, TTO for University of Oslo. Medinnova and Birkeland are now collectively known as Inven2. We are also strongly linked to the Radium Hospital Research Foundation (RF) and the Oslo Cancer Cluster (OCC). For more information about our investment opportunities, go to our Projects page.
Main Shareholders
| Shareholders |
% shares |
| Radiumhospitalets Forskningsstiftelse |
58,4 % |
| Springfondet / Forskningsparken |
12,9 % |
| Medinnova AS |
10,6 % |
| Dag Dvergsten AS |
4,8 % |
| Ingrid Alfheim |
1,8 % |
| Holstein AS |
1,1 % |
| Others |
10,4 % |
| TOTAL |
100,00 % |
Investor relations:
Phone: +47 22 95 81 90
E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
|
